NCT00305682
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
Clinical trial condition
Myeloproliferative Disorders
Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.
47 public trials
10 recruiting studies
Myeloproliferative Disorders trial results
NCT02580903
- Conditions
- Bone Marrow Diseases, Cardiovascular Diseases, Hematologic Diseases, +8 more
- Locations
-
- Odense University Hospital Odense, Denmark
NCT01787552
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
- Locations
-
- Novartis Investigative Site Camperdown, New South Wales, Australia
- Novartis Investigative Site Woolloongabba, Queensland, Australia
- Novartis Investigative Site Leuven, Belgium
- Novartis Investigative Site Toronto, Ontario, Canada
NCT01392989
- Conditions
- Anemia, Bone Marrow Diseases, Bone Marrow Transplant Failure, +14 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT02806375
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- First Pavlov State Medical University of St. Petersburg Saint Petersburg, Russia
NCT00061581
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +27 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
A Study in Myeloproliferative Disorders
NCT01134120
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salt Lake City, Utah, United States
Completed
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
NCT00361140
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +16 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT01413568
- Conditions
- Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Blood Protein Disorders, +36 more
- Locations
-
- University of Kansas Cancer Center Kansas City, Kansas, United States
- Washington University School of Medicine St Louis, Missouri, United States
Completed
B-Receptor Signaling in Cardiomyopathy
NCT01135849
- Conditions
- Adenocarcinoma, Adenoma, Amyloidosis, +140 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States